Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Consider a supervised dechallenge (temporary discontinuation) only when clinically safe and when the riskbenefit balance becomes unfavourable, documenting symptom response
Were global leaders in NAD+ research With 70,000+ NAD+ users supported and multiple peer-reviewed clinical trials, our in-house Stanford PhD-led Research Team is setting the benchmark for research-driven, clinician-guided NAD+ protocols
Every product is backed by 200+ published NABL lab reports, manufactured in FSSAI-certified, TV India GMP facilities, and meets FSSC 22000 V6 and ISO 22000 standards for safety and potency
Try to sip water throughout the day rather than drinking large amounts all at once
A Midi clinician can help you figure out which path makes sense for you
